776TiPPACTO: A single center, randomized, phase II study of the combination of nab-paclitaxel and gemcitabine with or without tocilizumab, an IL-6R inhibitor, as first-line treatment in patients with locally advanced or metastatic pancreatic cancer. (18th September 2017)

Record Type:
Journal Article
Title:
776TiPPACTO: A single center, randomized, phase II study of the combination of nab-paclitaxel and gemcitabine with or without tocilizumab, an IL-6R inhibitor, as first-line treatment in patients with locally advanced or metastatic pancreatic cancer. (18th September 2017)
Main Title:
776TiPPACTO: A single center, randomized, phase II study of the combination of nab-paclitaxel and gemcitabine with or without tocilizumab, an IL-6R inhibitor, as first-line treatment in patients with locally advanced or metastatic pancreatic cancer
Authors:
Chen, I.
Johansen, J.S.
Zimmers, T.A.
Dehlendorff, C.
Kirk Parner, V.
Vittrup Jensen, B.
Nielsen, D.
Abstract:
Is Part Of:
Annals of oncology. Volume 28(2017)Supplement 5
Journal:
Annals of oncology
Issue:
Volume 28(2017)Supplement 5
Issue Display:
Volume 28, Issue 5 (2017)
Year:
2017
Volume:
28
Issue:
5
Issue Sort Value:
2017-0028-0005-0000
Page Start:
Page End:
Publication Date:
2017-09-18
Subjects:
Oncology -- Periodicals
616.992
Journal URLs:
https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:
10.1093/annonc/mdx369.158 ↗
Languages:
English
ISSNs:
0923-7534
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
12574.xml